These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: Thalidomide--the story goes on...
    Author: Learned J.
    Journal: Notes Undergr; 1998; (No 37):1, 7, 9. PubMed ID: 11365815.
    Abstract:
    The FDA has approved Thalidomide under the brand name THALOMID. The manufacturer, Celgene Corporation, has developed a distribution and training program for THALOMID, to minimize the possibility of the potentially devastating side effects associated with the drug. The program requires doctors and pharmacies to register with the FDA before they can dispense the drug. Clinical trials of Thalidomide will still continue, even though approval has been granted. Contact information is included for information on trials and expanded access programs.
    [Abstract] [Full Text] [Related] [New Search]